Read more

April 06, 2022
1 min read
Save

Cefazolin may be safe option before surgery for patients with penicillin allergy labels

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

None of the patients with a penicillin allergy label who received cefazolin before surgery experienced allergic symptoms related to the antibiotic, according to a study published in Annals of Allergy, Asthma & Immunology.

Perspective from Allison C. Ramsey, MD

Patients with penicillin allergy labels (PALs) use cefazolin less frequently and are more likely to use alternative antibiotics, increasing surgical site infection risks, Jocelyn J. Cooper, MD, an internal medicine resident in the department of medicine at University of Washington, and colleagues wrote in the study.

Penicillin allergy
Source: Adobe Stock

The study queried the electronic medical records of 1,741 patients with PALs who had surgical procedures between Jan. 1 and Dec. 31, 2020, at University of Washington Medical Center.

Of these patients, 549 (white, 77.2%; women, 61.9%) used cefazolin before their surgery. Their PALs included all penicillin (52.3%), amoxicillin (28.6%) or amoxicillin-clavulanate (13.8%), with some PALs including multiple types of penicillin.

Also, 427 of these patients (77.8%) had documented index reactions, including rash (40%), gastrointestinal upset (25.3%), hives (20.6%), respiratory distress (1.9%), anaphylaxis (1.2%) and angioedema (0.7%).

However, 544 (99.1%) of the patients with PAL who received cefazolin had no documented postoperative allergic-type reaction, and the researchers did not consider the reactions in the five remaining patients to be related to the cefazolin.

Two of these patients had index reactions of rash and developed postoperative pruritis 4 hours after receiving cefazolin, which the researchers attributed to opioid medication. The third patient had index reactions of rash and hives and had intraoperative anaphylaxis 3 hours after the cefazolin dose.

The fourth patient had an index reaction of rash and developed postoperative pruritus, although there was no immediate reaction when cefazolin was administered 2.5 hours earlier, and the researchers listed the cause of this reaction as unknown.

The final patient had an index reaction of rash with intraoperative anaphylaxis 15 minutes after receiving cefazolin. Skin testing for cefazolin and penicillin during outpatient evaluation was negative, but it was positive for rocuronium, which the patient received immediately before the reaction.

Based on these findings, the researchers said that patients with a PAL could safely use cefazolin prophylactically before surgery. Also, the researchers plan to develop educational and clinical tools for making decisions to encourage doctors to use cefazolin in patients with PAL.